EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported third-quarter earnings of $136 million.
On a per-share basis, the Exton, Pennsylvania-based company said it had net income of $1.85.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.51 per share.
The medical device company posted revenue of $746.9 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $710.9 million.
West Pharmaceutical expects full-year earnings in the range of $6.55 to $6.75 per share, with revenue in the range of $2.88 billion to $2.91 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。